Tech Stocks emergin...
Health Care: Drugs
Abbott Laboratories (ABT: NYSE)
$37.51 0.62 | 1.68%
06/18/13 - 04:01 PM ET
5.45M / 7.05M
Vol / Avg. Vol:36.99 / 36.89
Open / Prev. Close:36.87 - 37.64
Today's Range:31.64 - 72.47
52 Wk Range:12.40%
Performance YTD:TheStreet Rating:
Portfolios with ABT
- Portfolio NameUser Type
- ContributorRocket Stocks for the Week ...
- UserDC
- UserCapt Jer
- UserBruce Watch List
- UserDividend Stocks
- ContributorStocks With Big Insider Buy...
- Usermiamisui Portfolio 1
- UserSteven O
- UserGlobo Gym Investments
- UserDividend
Latest ABT Headlines from TheStreet
- 5 Stocks Raising The Drugs Industry Higher 06.17.13 | 01:06 pm
- Cramer's 'Mad Money' Recap: Next Week's Game Plan 06.14.13 | 08:06 pm
- Abbott Laboratories (ABT): Today's Featured Health Services Laggard 06.12.13 | 05:06 pm
- Cramer's 'Mad Money' Recap: Profiting From Panic 06.11.13 | 08:06 pm
- 5 Drugs Stocks Dragging The Industry Down 06.11.13 | 01:06 pm
- Cramer's 'Mad Money' Recap: Accentuating the Negative 06.10.13 | 08:06 pm
- 'Mad Money' Lightning Round: The Bears Are Wrong on Hain 06.10.13 | 07:06 pm
- 5 Rocket Stocks to Buy After Last Week's Bounce 06.10.13 | 11:06 am
- Cramer's 6 Stocks in 60 Seconds: FHN WFM ABT PAY SAP MO (Update 1) 06.06.13 | 05:06 pm
- Abbott Laboratories (ABT): Today's Featured Health Services Laggard 06.05.13 | 05:06 pm
Press Releases for ABT
- Absolute Software Featuring Product Portfolio At Gartner IT Infrastructure & Operations Management Summit - PR Newswire 06.18.13 | 07:06 am
- Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend - PR Newswire 06.14.13 | 12:06 pm
- Absolute Software Commends The New York Attorney General And The San Francisco District Attorney Offices On The Smartphone Summit - PR Newswire 06.13.13 | 07:06 am
- Absolute Software Helps Recover More Than 300 Computers In Uganda - PR Newswire 06.12.13 | 05:06 pm
- Absolute Software Expands Managed Preference Settings To Mac OS X - PR Newswire 06.12.13 | 08:06 am
- Abbott Initiates Randomized Clinical Trial In Japan To Evaluate The Absorbâ¿¢ Bioresorbable Vascular Scaffold - PR Newswire 06.11.13 | 09:06 am
- Abbott To Present At Wells Fargo Securities Research & Economics 2013 Healthcare Conference - PR Newswire 06.10.13 | 08:06 am
- Absolute Software Onsite At Gartner Security & Risk Management Summit Showcasing Product Portfolio - PR Newswire 06.10.13 | 08:06 am
- Two Real-World European Studies Of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes For Patients With Mitral Regurgitation - PR Newswire 06.04.13 | 03:06 pm
- Abbott To Present At William Blair 33rd Annual Growth Stock Conference - PR Newswire 06.04.13 | 08:06 am
Partner Headlines for ABT
- Abbott Progresses with Absorb in Japan - Analyst Blog - Zacks 06.14.13 | 11:06 pm
- Biotechnology - Financial Times 06.12.13 | 11:06 pm
- Bear of the Day: Covidien (COV) - Bear of the Day - Zacks 06.12.13 | 10:06 am
- Abbott Begins Randomized Clinical Trial in Japan to Evaluate the Absorb™ Bioresorbable Vascular Scaffold - Benzinga 06.11.13 | 09:06 am
- UPDATE: Jefferies Lowers PT on Abbott Laboratories as Top US Pharma Pick - Benzinga 06.07.13 | 12:06 pm
- After Hours Most Active for Jun 3, 2013 : MMR, BAC, FE, ZNGA, NOK, GNW, MSFT, QQQ, ABT, SIRI, INTC, DTV - NASDAQ 06.03.13 | 08:06 pm
- Food safety a driver in Shuanghui's Smithfield deal - MSN Money 05.31.13 | 09:05 am
- Stocks Market News for May 30, 2013 - Market News - Zacks 05.30.13 | 03:05 pm
- CE Mark for Abbott's Xience Xpedition 48 - Analyst Blog - Zacks 05.23.13 | 12:05 am
- Near-Term Catalysts And High Insider Ownership Make GTx An Attractive Buy - Seeking Alpha 05.07.13 | 09:05 am
